Sonpavde G - Search Results

1

Prognostic and Predictive Factors in Patients with Advanced Penile Cancer Receiving Salvage (2nd or Later Line) Systemic Treatment: A Retrospective, Multi-Center Study.

Buonerba C, Di Lorenzo G, Pond G, Cartenì G, Scagliarini S, Rozzi A, Quevedo FJ, Dorff T, Nappi L, Lanzetta G, Pagliaro L, Eigl BJ, Naik G, Ferro M, Galdiero M, De Placido S, Sonpavde G. Buonerba C, et al. Among authors: sonpavde g. Front Pharmacol. 2016 Dec 20;7:487. doi: 10.3389/fphar.2016.00487. eCollection 2016. Front Pharmacol. 2016. PMID: 28066240 Free PMC article.

2

Serum alkaline phosphatase changes predict survival independent of PSA changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapy.

Sonpavde G, Pond GR, Berry WR, de Wit R, Armstrong AJ, Eisenberger MA, Tannock IF. Sonpavde G, et al. Urol Oncol. 2012 Sep;30(5):607-13. doi: 10.1016/j.urolonc.2010.07.002. Epub 2010 Oct 2. Urol Oncol. 2012. PMID: 20888271

3

The association between radiographic response and overall survival in men with metastatic castration-resistant prostate cancer receiving chemotherapy.

Sonpavde G, Pond GR, Berry WR, de Wit R, Eisenberger MA, Tannock IF, Armstrong AJ. Sonpavde G, et al. Cancer. 2011 Sep 1;117(17):3963-71. doi: 10.1002/cncr.25982. Epub 2011 Mar 1. Cancer. 2011. PMID: 21365623 Free PMC article.

4

Evaluating the value of number of cycles of docetaxel and prednisone in men with metastatic castration-resistant prostate cancer.

Pond GR, Armstrong AJ, Wood BA, Brookes M, Leopold L, Berry WR, de Wit R, Eisenberger MA, Tannock IF, Sonpavde G. Pond GR, et al. Among authors: sonpavde g. Eur Urol. 2012 Feb;61(2):363-9. doi: 10.1016/j.eururo.2011.06.034. Epub 2011 Jun 22. Eur Urol. 2012. PMID: 21715086 Free PMC article.

5

The role of sipuleucel-T in therapy for castration-resistant prostate cancer: a critical analysis of the literature.

Sonpavde G, Di Lorenzo G, Higano CS, Kantoff PW, Madan R, Shore ND. Sonpavde G, et al. Eur Urol. 2012 Apr;61(4):639-47. doi: 10.1016/j.eururo.2011.10.027. Epub 2011 Oct 24. Eur Urol. 2012. PMID: 22036643 Review.

6

Ability of C-reactive protein to complement multiple prognostic classifiers in men with metastatic castration resistant prostate cancer receiving docetaxel-based chemotherapy.

Pond GR, Armstrong AJ, Wood BA, Leopold L, Galsky MD, Sonpavde G. Pond GR, et al. Among authors: sonpavde g. BJU Int. 2012 Dec;110(11 Pt B):E461-8. doi: 10.1111/j.1464-410X.2012.11148.x. Epub 2012 Apr 23. BJU Int. 2012. PMID: 22520631 Clinical Trial.

7

Efficacy of docetaxel-based chemotherapy following ketoconazole in metastatic castration-resistant prostate cancer: implications for prior therapy in clinical trials.

Pond GR, Armstrong AJ, Galsky MD, Wood BA, Leopold L, Sonpavde G. Pond GR, et al. Among authors: sonpavde g. Urol Oncol. 2013 Nov;31(8):1457-63. doi: 10.1016/j.urolonc.2012.02.008. Epub 2012 May 1. Urol Oncol. 2013. PMID: 22552048 Clinical Trial.

8

Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis.

Di Lorenzo G, Buonerba C, Federico P, Perdonà S, Aieta M, Rescigno P, D'Aniello C, Puglia L, Petremolo A, Ferro M, Marinelli A, Palmieri G, Sonpavde G, Mirone V, De Placido S. Di Lorenzo G, et al. Among authors: sonpavde g. BJU Int. 2012 Dec;110(11 Pt B):E661-6. doi: 10.1111/j.1464-410X.2012.11453.x. Epub 2012 Sep 10. BJU Int. 2012. PMID: 22958571

9

Neutropenia as a potential pharmacodynamic marker for docetaxel-based chemotherapy in men with metastatic castration-resistant prostate cancer.

Pond GR, Berry WR, Galsky MD, Wood BA, Leopold L, Sonpavde G. Pond GR, et al. Among authors: sonpavde g. Clin Genitourin Cancer. 2012 Dec;10(4):239-45. doi: 10.1016/j.clgc.2012.06.004. Epub 2012 Sep 19. Clin Genitourin Cancer. 2012. PMID: 23000202 Clinical Trial.

10

New perspectives in the therapy of castration resistant prostate cancer.

Rescigno P, Buonerba C, Bellmunt J, Sonpavde G, De Placido S, Di Lorenzo G. Rescigno P, et al. Among authors: sonpavde g. Curr Drug Targets. 2012 Dec;13(13):1676-86. doi: 10.2174/138945012803529956. Curr Drug Targets. 2012. PMID: 23043326 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

508 results

Search Page

Filters